Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from IVD Medical Holding Limited ( (HK:1931) ) is now available.
IVD Medical Holding Limited reported a 6.2% decline in revenue and a 70% drop in profit for the first half of 2025 compared to the same period in 2024. The decrease in financial performance is attributed to reduced market demand, lower gross profit margins, increased administrative expenses, and higher selling and distribution costs due to technical service fees paid to a prospective partner.
The most recent analyst rating on (HK:1931) stock is a Hold with a HK$9.50 price target. To see the full list of analyst forecasts on IVD Medical Holding Limited stock, see the HK:1931 Stock Forecast page.
More about IVD Medical Holding Limited
IVD Medical Holding Limited operates in the medical industry, focusing on in vitro diagnostics. The company offers products and services related to chemiluminescence technology, catering to market demands for diagnostic solutions.
Average Trading Volume: 2,033,225
Technical Sentiment Signal: Buy
Current Market Cap: HK$13.59B
For a thorough assessment of 1931 stock, go to TipRanks’ Stock Analysis page.